ValiRx ValiRx ValiBio ValiPharma
ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
Shareholders Information
Live Quote
 
 
Aim Rule 26 Admission Document Advisors and Bankers Annual Reports Constitutional Document Corporate Governance Shareholders Information Shares in Issue Stock Information  

2009

AGM Notice July 2009

General Meeting Result 2009

Chairman's Letter 2009

Notice of General Meeting 2009

 

2008

ValiRx held its last Annual General Meeting on 28 July 2008 in London. The notice together with the Chairman's letter have been sent to shareholders and are also available for download by clicking below

AGM Result 2008

AGM Notice 2008

Form of Proxy 2008

General Meeting Result 2008

Chairman's Letter 2008

Notice of General Meeting 2008

 

2007

ValiRx held its first Annual General Meeting on 27th July 2007 in London. The notice of AGM together with the financial accounts for 2006 have been sent to shareholders and are also available for download by clicking on the links in PDF version:-

AGM Result 2007

AGM Notice 2007

Form of Proxy 2007

Notice to Shareholders 2007